Found 174 matching trials
Tocilizumab Dose-tapering and Interruption in Patients With Giant Cell Arteritis Achieving the Clinical Remission.
PHASE4Interleukin-6 (IL-6), a pro-inflammatory cytokine, has been found to have a...
Polymyalgia Rheumatica Associated to Primary Sjogren Syndrome
N/ATo determine the phenotype of patients having PMR symptoms and primary Sjog...
FDG Digital PET/CT as First Line Investigation for Giant Cell Arteritis
N/AGiant cell arteritis (GCA) causes inflammation of the arteries and can lead...
Location
Hôpital du Sacré-Cœur de Montréal
Using Personalized Rehabilitation to Reduce Disease and Increase Activity of Patients With Polymyalgia Rheumatica
NAPolymyalgia rheumatica (PMR) is a condition that causes joint pain and stif...
Location
Multiple Locations
A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell Arteritis
PHASE3This study consists of two periods. The objective of Period 1 is to evaluat...
Location
Rheum Assoc of North Alabama /ID# 168668
Study of T Lymphocytes in Patients With Horton Disease
NAGiant-cell arteritis (GCA) is the most frequent vasculitis after 50 years. ...
Location
CHU Dijon Bourgogne
Adjunctive Photodynamic Therapy + Aflibercept vs. Afilbercept Alone for PDA in NV AMD
NAThe purpose of this prospective interventional study is to assess whether a...
Tocilizumab Plus a Short Prednisone Taper for GCA
PHASE4This is an open-label pilot study of tocilizumab (TCZ) 162 mg weekly admini...
Location
Massachusetts General Hospital
Tocilizumab for Patients With Giant Cell Arteritis
PHASE2Giant-cell arteritis (GCA) is an immune-mediated disease that mostly affect...
Location
Department of Rheumatology, Clinical Immunology Allergology, University Hospital, Inselspital
Lymphocyte and Cytokine Disturbances in Polymyalgia Rheumatica
N/APathophysiology of polymyalgia rheumatica (PMR) is ill defined. This study ...